Inventor · disambiguated record
Brian Scott Garrison
Also filed as: GARRISON BRIAN SCOTT
4 granted patents·9 pending applications·8 citations·filing 2018–2024
66Inventor score
Top patents by PatentIndex Score
13 records- 0187US10993967B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2019·Granted May 4, 2021·5 cites·31 claims
- 0285US11419898B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2021·Granted Aug 23, 2022·2 cites·20 claims
- 0379US12005081B2Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2021·Granted Jun 11, 2024·1 cites·28 claims
- 0465US2022378842A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0565US2024277765A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0664US2023270789A1Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0762US2025032548A1Antigen-binding domains and methods of use thereofSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0862US2025041345A1Multicistronic chimeric protein expression systemsSENTI BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0959US11446332B2Combinatorial cancer immunotherapySENTI BIOSCIENCES INC·Filed 2018·Granted Sep 20, 2022·0 cites·18 claims
- 1058US2024042027A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1157US2023372486A1Chimeric receptors and methods of use thereofSENTI BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1251US2022378822A1Combinatorial cancer immunotherapySENTI BIOSCIENCE INC·Filed 2020·Application pending·0 cites
- 1344US2020085876A1Immunomodulating cell circuitsSENTI BIOSCIENCES INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Scott Garrison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →